Pharmacokinetics of idelalisib in chronic lymphocytic leukemia and follicular lymphoma disclose better outcomes for patients with lower exposure

Summary

This is a publication. If there is no link to the publication on this page, you can try the pre-formated search via the search engines listed on this page.

Authors: Fabien Despas, Maria Chaouki, Sandra de Barros, Baptiste Bonneau, Ben Allal, Julie Guillermet-Guibert, Loïc Ysebaert

Journal title: Leukemia & Lymphoma

Journal number: 65

Journal publisher: Taylor & Francis

Published year: 2024

Published pages: 1378-1380

DOI identifier: 10.1080/10428194.2024.2353330

ISSN: 1042-8194